Results 91 to 100 of about 1,278,172 (163)

719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Tyler Curiel   +11 more
doaj   +1 more source

San Antonio Nathan Shock Center: your one-stop shop for aging research. [PDF]

open access: yesGeroscience, 2021
Salmon AB   +13 more
europepmc   +1 more source

Perspectives on Geriatric Oncology Research Presented at the 2020 San Antonio Breast Cancer Symposium. [PDF]

open access: yesJ Geriatr Oncol, 2021
Hill A   +8 more
europepmc   +1 more source

298 Tumor cell-intrinsic mTORC1 signaling through raptor makes melanoma and ovarian cancer immunotherapy resistant by regulating interferon-gamma responsiveness and promoting tumor-initiating cells

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Tyler Curiel   +9 more
doaj   +1 more source

Patterns and characteristics of firearm thefts from vehicles in San Antonio, Texas. [PDF]

open access: yesInj Epidemiol
Testa A   +5 more
europepmc   +1 more source

Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty

open access: yesPlastic and Reconstructive Surgery, Global Open, 2017
Matthew Bindewald, MD   +9 more
doaj   +1 more source

242 Pharmacologic tumor PD-L1 depletion with chlorambucil treats ovarian cancer and melanomas in a tumor PD-L1-dependent manner and renders αPD-L1-resistant tumors αPD-L1-sensitive

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Tyler Curiel   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy